Advertisement

Preliminary study of a modified, nonflared, short, fully covered metal stent for refractory benign pancreatic duct strictures (with videos)

Published:November 15, 2019DOI:https://doi.org/10.1016/j.gie.2019.11.011

      Background and Aims

      Fully covered self-expanding metal stents (FCSEMSs) are considered to be more effective than plastic stents for the treatment of main pancreatic duct (MPD) strictures associated with chronic pancreatitis (CP) because of their larger diameter and exertion of a radial expansion force. However, the current FCSEMSs have several limitations. To overcome these, a novel modified nonflared FCSEMS was developed. In this study we conducted a prospective long-term follow-up evaluation of the efficacy of the novel FCSEMS for the treatment of refractory benign PD strictures in patients with CP.

      Methods

      Consecutive patients with symptomatic CP associated with refractory MPD strictures were enrolled prospectively in this single-arm study. The nonflared FCSEMS was placed intraductally or transpapillary according to the location and length of the stricture. Stent removal was performed at 3 months after placement. The primary outcome was the resolution of the pancreatic ductal stricture.

      Results

      Endoscopic placement of modified nonflared FCSEMSs was technically successful in all 25 patients. Intraductal FCSEMS placement was performed in 14 patients (56.0%). Stents of diameter 8 mm were used in 17 patients (68.0%). Stents of lengths 3 and 5 cm were inserted in 22 (88.0%) and 3 (12.0%) patients, respectively. In 1 patient (4.0%), stent migration developed. All other stents were removed successfully. After stent removal, resolution of the MPD stricture was confirmed in all patients, and no FCSEMS-related de novo stricture was observed. During the follow-up period (median, 34 months; interquartile range, 25-56) after the stents had been removed from the 25 patients, reintervention for recurrence of MPD stricture with abdominal pain was performed in 2 patients (8.0%).

      Conclusions

      Endoscopic placement of a novel modified nonflared FCSEMS resulted in long-term stricture resolution with pain relief and reduced the rate of stent-related adverse events, particularly stent migration and stent-induced de novo MPD stricture. (Clinical trial registration number: UMIN000035681.)

      Abbreviations:

      BPS (benign pancreatic duct stricture), CP (chronic pancreatitis), FCSEMS (fully covered self-expanding metal stent), IQR (interquartile range), MPD (main pancreatic duct), PD (pancreatic duct)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Gastrointestinal Endoscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dumonceau J.M.
        • Delhaye M.
        • Tringali A.
        • et al.
        Endoscopic treatment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline—updated August 2018.
        Endoscopy. 2019; 51: 179-193
        • Eleftherladis N.
        • Dinu F.
        • Delhaye M.
        • et al.
        Long-term outcome after pancreatic stenting in severe chronic pancreatitis.
        Endoscopy. 2005; 37: 223-230
        • Farnbacher M.J.
        • Muhldorfer S.
        • Wehler M.
        • et al.
        Interventional endoscopic therapy in chronic pancreatitis including temporary stenting: A definitive treatment?.
        Scand J Gastroenterol. 2006; 41: 111-117
        • Cahen D.L.
        • Gouma D.J.
        • Nio Y.
        • et al.
        Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis.
        N Engl J Med. 2007; 356: 676-684
        • Rösch T.
        • Daniel S.
        • Scholz M.
        • et al.
        Endoscopic treatment of chronic pancreatitis: a multicenter study of 1000 patients with long-term follow-up.
        Endoscopy. 2002; 34: 765-771
        • Costamagna G.
        • Bulajic M.
        • Tringali A.
        • et al.
        Multiple stenting of refractory pancreatic duct strictures in severe chronic pancreatitis: long-term results.
        Endoscopy. 2006; 38: 254-259
        • Tringali A.
        • Vadala di Prampero S.F.
        • Landi R.
        • et al.
        Fully covered self-expandable metal stents to dilate persistent pancreatic strictures in chronic pancreatitis: long-term follow-up from a prospective study.
        Gastrointest Endosc. 2018; 88: 939-946
        • Park D.H.
        • Kim M.H.
        • Moon S.H.
        • et al.
        Feasibility and safety of placement of a newly designed, fully covered self-expandable metal stent for refractory benign pancreatic ductal strictures: a pilot study (with video).
        Gastrointest Endosc. 2008; 68: 1182-1189
        • Moon S.H.
        • Kim M.H.
        • Park D.H.
        • et al.
        Modified fully covered self-expandable metal stents with antimigration features for benign pancreatic-duct strictures in advanced chronic pancreatitis, with a focus on the safety profile and reducing migration.
        Gastrointest Endosc. 2010; 72: 86-91
        • Matsubara S.
        • Sasahira N.
        • Isayama H.
        • et al.
        Prospective pilot study of fully covered self-expandable metal stents for refractory benign pancreatic duct strictures: long-term outcomes.
        Endosc Int Open. 2016; 4: E1215-E1222
        • Gupta R.
        • Reddy D.N.
        Stent selection for both biliary and pancreatic strictures caused by chronic pancreatitis: multiple plastic stents or metallic stents?.
        J Hepatobiliary Pancreat Sci. 2011; 18: 636-639
        • Kozarek R.
        • Hovde O.
        • Attia F.
        • et al.
        Do pancreatic duct stents cause or prevent pancreatic sepsis?.
        Gastrointest Endosc. 2003; 58: 505-509
        • Cotton P.B.
        • Eisen G.M.
        • Aabakken L.
        • et al.
        A lexicon for endoscopic adverse events: report of an ASGE workshop.
        Gastrointest Endosc. 2010; 71: 446-454
        • Giacino C.
        • Grandval P.
        • Laugier R.
        Fully covered self-expanding metal stents for refractory pancreatic duct strictures in chronic pancreatitis.
        Endoscopy. 2012; 44: 874-877
        • Korpela T.
        • Udd M.
        • Lindstrom O.
        • et al.
        Fully covered self-expanding metal stents for benign refractory pancreatic duct strictures in chronic pancreatitis.
        Scand J Gastroenterol. 2019; 54: 365-370

      Linked Article